In addition it addresses the FDA’s communications Using the applicant, the retention of documents that support the SE report, confidentiality of the SE report, how an applicant can amend or withdraw an SE report, how an applicant may transfer possession of an SE report back to a new applicant and Digital submission on the SE report and amendments